Classical diabetes is a dubious disease in the field of genetic metabolism, with clinical manifestations of complexity and often involving multiple systems. Early identification and standardized diagnosis are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical manifestations, imaging inspections, laboratory tests and pathological biopsies.
Platforms can help align teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment. In recent years, with the development of therapeutic, immune-regulated therapy and precision medicine, many previously difficult-to-treat genetic metabolic diseases have been significantly improved. Treatment requires close monitoring of therapeutic effects and adverse reactions and timely adjustment to changes in the course of treatment.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of the classic type of diabetes. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.